DMT Harm Reduction:
Know Which One You Have.
Two substances get called "DMT". N,N-DMT is the classic smoked tryptamine and the active psychedelic in ayahuasca. 5-MeO-DMT is a separate compound that is active at much smaller amounts, feels nothing like it, and has a narrower margin for error. They are sometimes sold interchangeably. Beyond that, the biggest real-world danger with DMT is not the DMT: it is the MAOI that has to be added to make it work orally, and what that MAOI does to antidepressants and other serotonergic drugs.
This is not medical advice. DMT and 5-MeO-DMT are Schedule I in the US and controlled in most jurisdictions. If someone is unresponsive, rigid, overheating, or having trouble breathing, call emergency services. Some links on this page are affiliate links, we may earn a commission at no extra cost to you.
What is DMT?
Chemistry
N,N-dimethyltryptamine is a simple indole tryptamine found in many plants and produced in trace amounts in mammals. It is the active psychedelic in ayahuasca and the substance usually meant by "smoking DMT". Schedule I in the US.
Mechanism
Agonist at 5-HT2A and other serotonin receptors, the same family as psilocybin and LSD. Because it is a substrate for monoamine oxidase, the body clears it very fast, which is why the smoked experience is measured in minutes rather than hours.
Routes
Vaporised or smoked (seconds to onset, over in minutes), injected in research settings, or taken orally with an MAOI as ayahuasca or pharmahuasca. Swallowed on its own it does close to nothing.
Supply risk
Sold as loose crystal, in "changa" herbal blends, or in sealed vape carts. Carts are the hardest to verify: you cannot see, weigh, or reagent-test a filled cartridge without emptying it, and the label is the only claim you have.
5-MeO-DMT is not N,N-DMT
Two different molecules, two different drugs. 5-MeO-DMT is active in the single-digit milligram range vaporised, where N,N-DMT is dosed in tens of milligrams. The subjective effects barely resemble each other. They are sometimes substituted for one another in the illicit market, and no home reagent can separate them because both are indoles. Full breakdown below.
Critical risks
MAOI plus serotonergic drugs
Ayahuasca means taking an MAOI. MAOIs combined with SSRIs, SNRIs, MDMA, tramadol, or other serotonergic drugs can cause serotonin syndrome, and combined with tyramine-rich foods can cause hypertensive crisis. This is the single largest source of preventable harm around DMT.
The wrong tryptamine
Taking an N,N-DMT-sized dose of 5-MeO-DMT is a serious overdose. If you cannot establish which compound you have, you do not have a dose, you have a guess.
Falling and burns
Smoked DMT takes effect faster than you can put anything down. People drop lit pipes, slump into hot glass, and fall. Sit or lie down first, and have someone sober take the pipe out of your hand.
Blood pressure spike
Controlled intravenous dosing raised blood pressure, heart rate, pupil diameter, and body temperature dose-dependently. If you have uncontrolled hypertension or a known cardiac condition, that acute surge is a real reason not to.
N,N-DMT vs 5-MeO-DMT
Both get called DMT in conversation and on packaging. Treating them as the same substance is the most consequential mistake people make with this class of drug, and it is the reason this section comes before dosing.
N,N-DMT, the classic
- Potency: vaporised doses are commonly reported in the tens of milligrams
- Character: intensely visual, geometric, often described as entering a distinct scene or environment
- Duration smoked: seconds to onset, roughly 5 to 20 minutes total
- Oral: inactive alone, active only with an MAOI (ayahuasca, pharmahuasca)
- Where it comes from: plant sources such as Mimosa and Acacia species, or synthesised
5-MeO-DMT, the other one
Different drug- Potency: active in the single-digit milligram range vaporised, so a scoop sized for N,N-DMT is a large overdose
- Character: usually described as non-visual and totally overwhelming, with loss of any sense of self or surroundings. People go rigid, thrash, vocalise, or vomit
- Receptor profile: a nonselective serotonin agonist with its highest affinity at 5-HT1A, not the 5-HT2A-dominant profile people expect from a psychedelic
- Metabolism: broken down mainly by MAO-A and converted by CYP2D6 into bufotenine, which is itself active. CYP2D6 varies a lot between people, so the same dose does not do the same thing to everyone
- With an MAOI: clearance is blocked and exposure rises sharply. A forensic case report describes a death after 5-MeO-DMT was drunk in an ayahuasca-style brew containing harmine, harmaline, and tetrahydroharmine
- Source: synthesised, or from Bufo alvarius toad secretion, where concentration is not standardised in any way
How to tell them apart
Honestly: at home, you mostly cannot. Both are indoles, so both turn Ehrlich purple. Neither has a widely available home reagent that separates it from the other. What you can do:
- Send a sample to a lab drug-checking service that runs GC-MS or FTIR. This is the only reliable answer
- Treat any unlabelled white or off-white tryptamine crystal as unidentified, not as N,N-DMT by default
- Be suspicious of vape carts specifically. A sealed cart cannot be weighed or reagent-tested without emptying it, and 5-MeO-DMT has turned up in products sold as DMT
- If you cannot confirm the identity, the safe move is not a smaller dose of an unknown, it is not dosing
The MAOI problem: ayahuasca and your medication
If you are drinking ayahuasca or taking pharmahuasca capsules, you are taking a monoamine oxidase inhibitor. That single fact drives almost every serious interaction on this page.
Why oral DMT needs an MAOI
Monoamine oxidase in the gut wall and liver destroys DMT before meaningful amounts reach the brain, so swallowing DMT on its own produces little or nothing. Ayahuasca solves this by pairing a DMT-containing plant with Banisteriopsis caapi, whose harmala alkaloids (harmine, harmaline, tetrahydroharmine) inhibit MAO-A. Pharmahuasca does the same thing with isolated DMT plus harmine in a capsule. Self-experiments with pharmahuasca confirmed this mechanism directly, and it is the reason the oral route works at all.
Practical consequence: the MAOI stays active in your body for hours after the DMT is gone. The interaction window is not the length of the trip.
SSRIs, SNRIs, and antidepressants
CriticalAn MAOI on top of an SSRI or SNRI is a textbook serotonin syndrome combination and is contraindicated in ordinary psychiatric practice, entirely separately from any psychedelic context. Ayahuasca does not get an exemption from that pharmacology.
An important distinction people get wrong: recent reviews of taking antidepressants alongside classic psychedelics such as psilocybin found the combination generally tolerable without increased serotonin syndrome risk. That finding is about psilocybin and similar 5-HT2A agonists on their own. It does not transfer to ayahuasca, because ayahuasca adds an MAOI to the picture and the MAOI is what makes the interaction dangerous.
The other half of this is real too: stopping an antidepressant abruptly to attend a ceremony carries its own risk, including discontinuation effects and relapse of the condition you were treating. This is a conversation with a prescriber, not a decision to make off a website or from a facilitator's advice. If you cannot taper safely under supervision, the answer is to skip the ceremony.
How to recognise serotonin syndrome →Do not combine with an MAOI
CriticalSerotonin syndrome warning signs
Onset is usually within hours of the triggering dose. The combination of these signs matters more than any one of them:
- Agitation, restlessness, confusion, rapid speech
- Muscle twitching, tremor, rigidity, and clonus (rhythmic involuntary jerking, most obvious at the ankles)
- Heavy sweating, shivering, dilated pupils, diarrhoea
- Fast heart rate, high blood pressure, rising temperature
What ayahuasca normally does
In the Global Ayahuasca Survey of more than 10,000 participants, about 70 percent reported an acute physical adverse effect, overwhelmingly vomiting, and 2.3 percent needed medical attention afterwards. Around 56 percent reported some adverse mental health effect in the following weeks, although most of those people framed it as part of a difficult but useful process, and about 12 percent sought professional support for it.
- Vomiting and diarrhoea are expected, not a sign something went wrong. Plan for fluids afterwards
- Physical adverse effects were more likely in people with an existing physical health condition and in people drinking outside a supervised setting
- Adverse mental health effects were more likely in people with an anxiety disorder
- Brew strength is not standardised. The same volume from a different batch is not the same dose
Testing: what Ehrlich can and cannot tell you
Reagent testing for DMT is a rule-out tool, not an identification. Understanding exactly what the purple means keeps you from over-trusting it.
Ehrlich reagent
Ehrlich's is p-dimethylaminobenzaldehyde in acid. It condenses with the electron-rich indole ring and produces a purple product. That is the entire mechanism, and it explains both the value and the limit.
Some links here are affiliate links and we may earn a commission at no extra cost to you. DanceSafe sells Ehrlich as its LSD kit, which is the same reagent you would use on a tryptamine.
Ehrlich (LSD) kit at DanceSafe → Full Ehrlich color chart →Lab drug checking
Because no home reagent separates N,N-DMT from 5-MeO-DMT, a lab service running GC-MS or FTIR is the only way to actually identify what you have. If the identity matters to you, and with these two compounds it should, this is the step that answers the question.
Scales and fentanyl strips
Weigh crystal rather than eyeballing it. The gap between a light smoked dose and a full breakthrough is small enough in milligrams that a visual estimate is not a dose.
Fentanyl contamination is not a documented feature of the DMT supply the way it is for opioids and some stimulant powders, so strips are not the priority here. If your source also handles powders where contamination does happen, or you have any doubt about what a shared bag has touched, strips are inexpensive insurance.
Dose and timeline
Route changes this drug more than dose does. The same compound gives you a twelve-minute experience or a five-hour one depending entirely on how it enters your body.
Smoked or vaporised N,N-DMT
Onset is within seconds of the first full inhalation. In controlled intravenous dosing, blood levels and subjective effects peaked within about two minutes and were negligible by thirty minutes. Smoked material follows a similar shape.
Because the window is so short, the temptation to immediately redose is strong. Repeated closely spaced dosing is not a neutral act: it stacks cardiovascular effects while, unusually, the subjective effects do not blunt. See the tolerance section below.
Oral (ayahuasca, pharmahuasca)
Plain oral DMT is inactive. With an MAOI, onset is typically 30 to 60 minutes, the peak sits around one to two hours, and the whole thing runs roughly four to six hours, with the MAOI itself active for longer.
- Brew concentration varies between batches, preparers, and traditions. There is no reliable way to know the DMT content of a cup by looking at it
- Do not treat a second cup as a proportional step up. Onset is slow enough that people misjudge it and drink again too early
- The dietary and medication restrictions before a ceremony exist because of the MAOI, not for ritual reasons alone
- Vomiting is common and expected
Changa and vape carts
Changa is DMT infused into a herbal blend, often with a caapi or Syrian rue component, which means it can carry a small MAOI dose alongside the DMT. If you take an SSRI or SNRI, or you are dosing anything else serotonergic, changa is not a lower-commitment option, it is a smaller version of the same interaction.
Vape carts split what would be one hit into many small ones. That changes the shape of the experience, makes accidental stacking easy, and removes your ability to inspect or weigh the material. Treat a cart of unknown provenance as an unidentified tryptamine at an unknown concentration.
Physical safety and the sitter
Most of what goes physically wrong with smoked DMT is mundane: burns and falls. The onset is faster than your reaction time, so every precaution has to be in place before the first inhalation.
Before you light anything
- Sit or lie down first. Not "I will sit down after". You will not have time. Standing is how people fall into furniture and hard floors
- Have a sober sitter. Their first job is taking the pipe or vape out of your hand the moment you stop inhaling
- Clear the area. No candles, no open flame, no glass tables, no stairs, no water, no balcony, no fireplace edges
- Use a stable surface. A floor with cushions beats a couch you can roll off. Beds are fine if there is nothing hard beside them
- Set the pipe down on something heatproof. Hot glass on a carpet or a duvet is a fire, and hot glass against skin is a burn you will not feel happening
- Agree the plan out loud beforehand. The sitter should know what was taken, roughly how much, and that they are not to intervene physically unless there is a safety issue
What a sitter actually does
- Takes the pipe, puts it somewhere safe, stays within reach
- Does not talk, touch, or intervene unless the person is at physical risk
- Keeps them from standing or wandering for the first several minutes
- Watches for choking if the person vomits, and turns them onto their side if they are unresponsive and lying flat
- Stays sober. A sitter who has also dosed is a second person needing supervision
- Knows when to call for help and is willing to do it. In an emergency say what was taken, honestly
With 5-MeO-DMT the sitter role is more physical, not less. Rigidity, thrashing, and unresponsiveness are commonly described, and someone needs to be there to keep the person from injuring themselves.
Difficult experiences
A frightening DMT experience is short by construction. That is genuinely useful information to hold onto, and worth saying to someone out loud if you are sitting for them.
- Slow breathing helps more than anything else. Long exhales
- Do not fight it. Resistance during the peak tends to make it harder, and the peak passes on its own in minutes regardless
- Fireside Project (62-FIRESIDE) takes calls and texts during and after psychedelic experiences
- Oral doses do not have this escape hatch. An ayahuasca session you want out of still has hours left to run, which is why setting and support matter far more there
- If distress persists for days afterwards, that is worth taking to a clinician rather than waiting out
Who should not take DMT
These are the risk factors with the clearest basis. None of them are absolute predictions, and all of them are reasons to take the decision seriously rather than casually.
Psychosis history
A personal or first-degree family history of schizophrenia, schizoaffective disorder, or bipolar disorder with psychotic features is a standard exclusion in every psychedelic clinical trial protocol, for good reason. Serotonergic psychedelics can precipitate or worsen psychotic episodes in vulnerable people. Family history counts even if you have never had symptoms yourself.
Cardiovascular conditions
Controlled dosing produced dose-dependent rises in blood pressure and heart rate. Uncontrolled hypertension, arrhythmia, structural heart disease, or a history of cardiac events all make that acute surge a meaningful risk. With an MAOI on board, the hypertensive crisis risk from any sympathomimetic or tyramine exposure is added on top.
Pregnancy
There is no safety data on DMT or ayahuasca in pregnancy, and the alkaloids cross biological barriers. Harmala alkaloids in particular have uterine effects described in the older literature. Absence of data here is not reassurance, it means the risk is unquantified. The same applies while breastfeeding.
Serotonergic medication
Any SSRI, SNRI, MAOI, tricyclic, tramadol, triptan, lithium, or St John's wort. For smoked N,N-DMT the concern is additive serotonergic load. For anything involving an MAOI it moves from concern to contraindication.
Liver conditions
Ayahuasca alkaloids are hepatically metabolised and interact with CYP enzymes. Existing liver disease or a medication regimen that already loads the liver is a reason to get clinical advice rather than proceed on a facilitator's assurance.
Tolerance and dependence
DMT behaves differently here from the rest of the psychedelic class, and that difference has a practical consequence.
Tolerance does not build the usual way
LSD and psilocybin build strong, fast tolerance: dose again the next day and the effect is markedly reduced. DMT does not follow that pattern. In a controlled study where volunteers received four hallucinogenic intravenous doses spaced thirty minutes apart, tolerance to the psychedelic subjective effects did not develop, by either clinical interview or rating scale. Hormonal responses and heart rate response did decline with repetition, while blood pressure response did not.
The harm reduction reading of that result: repeat dosing keeps working psychologically, so nothing in the experience tells you to stop, while cardiovascular effects are still landing each time. Decide your number of doses before you start rather than in the moment.
What DMT does not do
- No documented physical withdrawal syndrome. Unlike alcohol, benzodiazepines, or opioids, stopping does not produce a recognised withdrawal state
- Compulsive use is uncommon. In a survey of 515 people who had used 5-MeO-DMT, most had used fewer than four times in their life and under ten percent reported any craving or desire for the drug. Reported legal, medical, and psychiatric problems related to use were each around one percent
- That is not the same as harmless. Low dependence liability says nothing about acute risk, the MAOI interactions, psychological difficulty, or what happens when the identity of the substance is wrong
- Survey data is self-reported and drawn from people willing to answer a psychedelics questionnaire, which is not a representative sample. Read it as a signal about dependence patterns, not as a safety guarantee
Legal status
Brief and factual. This is not legal advice, and the specifics vary by country and by state or province.
United States
DMT is a Schedule I controlled substance under the federal Controlled Substances Act. 5-MeO-DMT was added to Schedule I in 2011. Plants containing DMT occupy an odd position: the plant material itself is generally not scheduled, while extracting the DMT from it is a controlled substance offence.
There is a narrow religious-use exemption, established through litigation rather than legislation. In Gonzales v. O Centro Espírita Beneficente União do Vegetal (2006) the Supreme Court ruled unanimously under the Religious Freedom Restoration Act that the UDV could use its ayahuasca sacrament. A later federal district court ruling extended comparable protection to a Santo Daime congregation in Oregon. These exemptions apply to those specific religious bodies. They are not a general legal shelter for ceremonies, retreats, or facilitators, and buying a seat at a ceremony does not put you inside one.
Elsewhere
DMT is controlled under the 1971 UN Convention on Psychotropic Substances, so it is prohibited in most countries. National handling of ayahuasca as a preparation differs considerably: Brazil and Peru permit religious and traditional use, while several European countries have prosecuted ayahuasca cases with inconsistent outcomes.
Carrying DMT or ayahuasca across a border is a separate and more serious offence than possession in most jurisdictions, including where domestic ceremonial use is tolerated. Check the law where you actually are, and treat retreat marketing as advertising rather than as legal information.
Research and further reading
Human research on DMT is unusually good for a Schedule I tryptamine, largely because of one controlled programme in the 1990s. Research on 5-MeO-DMT is much thinner, and most of what is known about it comes from survey and metabolic work rather than clinical trials.
Strassman & Qualls (1994), dose-response in humans
Double-blind, placebo-controlled intravenous dosing in 11 experienced hallucinogen users. Peak blood levels and subjective effects within two minutes, negligible at thirty. Blood pressure, heart rate, pupil diameter, and body temperature all rose dose-dependently. This anchors both the timeline and the cardiovascular warning on this page.
Strassman RJ, Qualls CR (1994). Dose-response study of N,N-dimethyltryptamine in humans. I. Neuroendocrine, autonomic, and cardiovascular effects. Arch Gen Psychiatry. PMID 8297216 →Strassman et al. (1996), differential tolerance
Thirteen volunteers received four hallucinogenic intravenous doses at thirty-minute intervals. Tolerance to the subjective psychedelic effects did not occur, while ACTH, prolactin, cortisol, and heart rate responses declined and blood pressure response did not. This is the source for the tolerance section above.
Strassman RJ, Qualls CR, Berg LM (1996). Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans. Biol Psychiatry. PMID 8731519 →Ott (1999), pharmahuasca
Summary of roughly seventy self-experiments with capsules of crystalline DMT plus harmine. Confirms the Holmstedt-Lindgren hypothesis that oral DMT becomes active because the beta-carboline inhibits monoamine oxidase. This is the direct evidence behind the claim that oral DMT is inactive without an MAOI.
Ott J (1999). Pharmahuasca: human pharmacology of oral DMT plus harmine. J Psychoactive Drugs. PMID 10438001 →Sklerov et al. (2005), fatal 5-MeO-DMT intoxication
A 25-year-old man died after drinking herbal extracts containing beta-carbolines and tryptamines. Heart blood contained 5-MeO-DMT at 1.88 mg/L alongside harmine, harmaline, and tetrahydroharmine, with only trace N,N-DMT. No anatomic cause of death was found at autopsy and the medical examiner ruled hallucinogenic amine intoxication. This is the documented case behind the 5-MeO-DMT plus MAOI warning.
Sklerov J et al. (2005). A fatal intoxication following the ingestion of 5-methoxy-N,N-dimethyltryptamine in an ayahuasca preparation. J Anal Toxicol. PMID 16356341 →Shen et al. (2010), 5-MeO-DMT metabolism and interactions
Review of how 5-MeO-DMT is handled by the body. It is inactivated mainly by MAO-A and converted by CYP2D6 into the active metabolite bufotenine. Adding harmaline blocks the deamination route, prolonging and increasing exposure to both, which the authors describe as a route to hyperserotonergic effects and serotonin toxicity. CYP2D6 genetic variation adds further unpredictability.
Shen HW, Jiang XL, Winter JC, Yu AM (2010). Psychedelic 5-methoxy-N,N-dimethyltryptamine: metabolism, pharmacokinetics, drug interactions, and pharmacological actions. Curr Drug Metab. PMID 20942780 →Ermakova et al. (2022), narrative synthesis
Literature review covering the pharmacology, chemistry, and metabolism of 5-MeO-DMT. Identifies it as a serotonergic agonist with highest affinity for 5-HT1A, notes its short duration and relative lack of visual effects compared with other psychedelics, and states plainly that clinical studies in humans are lacking.
Ermakova AO, Dunbar F, Rucker J, Johnson MW (2022). A narrative synthesis of research with 5-MeO-DMT. J Psychopharmacol. PMID 34666554 →Bouso et al. (2022), Global Ayahuasca Survey
Survey of 10,836 ayahuasca drinkers across more than 50 countries. Around 70 percent reported acute physical adverse effects, mainly vomiting, with 2.3 percent requiring medical attention. Adverse mental health effects in following weeks were reported by around 56 percent, most of whom framed them as part of a growth process, with about 12 percent seeking professional support.
Bouso JC et al. (2022). Adverse effects of ayahuasca: Results from the Global Ayahuasca Survey. PLOS Glob Public Health. PMID 36962494 →Tap et al. (2025), antidepressants with classic psychedelics
Scoping review of 18 studies on taking conventional antidepressants alongside classic psychedelics. Found the combination generally safe and tolerable without increased serotonin syndrome risk, particularly for psilocybin, and argued that forced discontinuation carries its own harms. Read this as being about psilocybin-type psychedelics, not about ayahuasca, where the MAOI changes the picture entirely.
Tap SC et al. (2025). Concomitant use of antidepressants and classic psychedelics: A scoping review. J Psychopharmacol. PMID 40937732 →Flockhart (2012), MAOI dietary and drug interactions
Clinical pharmacology review of what MAOIs interact with. Covers hypertensive crisis from tyramine-containing foods and serotonin syndrome from serotonergic and sympathomimetic agents. Written for prescribers, but it is the same enzyme inhibition that ayahuasca produces, and it is the basis for the food and medication list above.
Flockhart DA (2012). Dietary restrictions and drug interactions with monoamine oxidase inhibitors: an update. J Clin Psychiatry. PMID 22951238 →Davis et al. (2018), 5-MeO-DMT epidemiology
Web survey of 515 people who had used 5-MeO-DMT. Most had used it fewer than four times in their lifetime and less than once a year. Under 10 percent reported craving or desire for the drug, and around 1 percent each reported legal, medical, or psychiatric problems related to use. The authors conclude a low potential for addiction. Self-selected sample, so treat it as a signal rather than a population estimate.
Davis AK et al. (2018). The epidemiology of 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) use. J Psychopharmacol. PMID 29708042 →TripSit DMT page
Community-maintained dose ranges, duration, and a combination checker. Useful for checking a specific pairing before you commit to it.
TripSit: DMT →Drug checking services
Because Ehrlich cannot separate N,N-DMT from 5-MeO-DMT, laboratory analysis is the only way to identify a sample. Energy Control operates an international mail-in service and publishes aggregate results.
Energy Control (international analytics) →Related guides
Psilocybin guide
Dosing, species potency variation, contraindications, and how the tryptamine cousin differs
LSD guide
Set and setting, Ehrlich testing, the lithium interaction, and difficult experiences
Interaction chart
Every combination on the site, including DMT with MAOIs, MDMA, and antidepressants
Harm reduction FAQ
Common questions on testing, dosing, and emergencies across every substance
Reagent color chart
What every reagent turns for every substance, in one table
Which test kit do I need?
Matching reagents to what you actually have, and where reagents stop being useful
DMT testing kit
Affiliate disclosure: links may earn a commission at no extra cost to you. Products selected for harm reduction value only.
Ehrlich reagent (sold as the LSD kit)
The one reagent that reacts with tryptamines. It confirms an indole is present and rules out non-indole substitutes. It will not tell you whether you have N,N-DMT or 5-MeO-DMT, so read the testing section above before relying on it.
Complete reagent set
All nine DanceSafe reagents together. Worth it if you test more than one class of substance, since Ehrlich alone covers only indoles.
Fentanyl test strips
Not a routine step for DMT crystal specifically, but useful if the same source or environment also handles powders where contamination is a documented problem.
From the Blog
Longer pieces on tryptamine identification, reagent limits, and serotonin risk.
Identification
DMT Vapes and Microdosing: What to Know
A sealed cart cannot be weighed or reagent-tested, and 5-MeO-DMT has been sold inside them. What you can and cannot verify.
Drug Checking
Ehrlich Reagent Color Chart and How to Read It
Purple means an indole. Why that covers LSD, DMT, and psilocybin equally, and what a non-reaction actually tells you.
Emergencies
Serotonin Syndrome: How to Recognize It and What to Do
Clonus, hyperthermia, and rigidity. The signs that separate a rough experience from an emergency, and what to tell paramedics.
Interactions
Psychedelics and Antidepressants
Why the SSRI question has a different answer for psilocybin than it does for anything involving an MAOI.